Revive Therapeutics Ltd: MDA EN

SEDAROct 28 20:19 ET · Announcements

Revive Therapeutics Ltd: AUDITED ANNUAL FINANCIAL STATEMENTS EN

SEDAROct 28 18:42 ET · Announcements

Express News | Revive Therapeutics Ltd: Decided Not to Pursue Development of Long Covid Diagnostic Product

ReutersSep 18 07:00 ET

Express News | Revive Therapeutics Ltd - Additional Phase 3 Clinical Trial Data Analyses May Suggest Bucillamine's Potential for Long Covid.

ReutersJun 12 09:06 ET

Express News | Revive Therapeutics Ltd - FDA Has Recommended That Evaluation of Bucillamine for Long Covid Be Submitted as a New Ind Application

ReutersJun 12 09:06 ET

Express News | Revive Therapeutics Ltd - Company Is Exploring Use of Bucillamine as a Potential Treatment for Long Covid

ReutersJun 12 09:06 ET